Patient Perspective of the Corporate Reputation of Pharma in Asia, 2017-2018

Friday, 16. August 2019 10:11

Dublin, Aug. 16, 2019 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma, 2017 - The Patient Perspective - Asia Edition" report has been added to ResearchAndMarkets.com's offering.

Introducing the results of the 2017 (2nd) edition of The Corporate Reputation of Pharma-from the Perspective of Asian Patient Groups'. In total, 101 Asian patient groups from across the region participated in the 2017 survey (with 35% of the respondents being based in Australasia).

The 18 companies included in the 2017 Asia analysis are: AbbVie, Astellas Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly (Lilly), Gilead Sciences, GSK, Janssen, Merck & Co/MSD, Novartis, Otsuka, Pfizer, Roche, Sanofi and Takeda.

Asian patient groups (and the patients they represent), on the whole, take a more positive view of the pharmaceutical industry than patient groups from elsewhere in the world. As many as 51% of the respondent Asian patient groups stated that the pharmaceutical industry as a whole had an Excellent or Good corporate reputation in 2017 (on a par with the 50% of Asian patient groups saying the same in 2016). The equivalent figure from patient groups worldwide in 2017 was 43%.

Key Topics Covered:

  1. Executive Summary
  2. The Relationships That Asian Patient Groups Have With Pharma, 2017
  3. Industry-Wide Findings From Asian Patient Groups, 2017
  4. Rankings Of The 18 Pharma Companies, 2017 V. 2016 Among Asian Patient Groups Familiar With The Companies
  5. Positionings Of 11 Pharma Companies, 2017 V. 2016 Among Asian Patient Groups That Work/Partner With The Companies
  6. Profiles Of The 18 Companies, 2017

Appendices

I. Asian Patient Groups: Their Views On Pharma And Their Recommendations For Improvement
II. Profiles Of The 101 Respondent Asian Patient Groups, 2017

Companies Mentioned

  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eisai
  • Eli Lilly (Lilly)
  • GSK
  • Gilead Sciences
  • Janssen
  • Merck & Co/MSD
  • Novartis
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Takeda

For more information about this report visit https://www.researchandmarkets.com/r/smwnkv

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

Related Links: 
Author:
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.